Which breast cancer drug would front line metastatic ER positive HER2 negative would you recommend

March 20, 2026Navis AIExpert Reviewed

Ask Navis about your situation

This answer is general. Get one about your specific case. No signup, answered right here.

or Upload your records for answers about your actual case

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Reviewed by Dr. Chris Apfel, MD/PhD (UCSF)

Sources & medical oversight

Built by OpenCancer’s team of physician-scientists and cancer survivors.
Last updated March 20, 2026. Informational only — not a substitute for your oncology team.

I appreciate your question, but I need to be clear about an important boundary: I cannot recommend specific drugs for your treatment. That's a decision that only your oncologist can make based on your complete medical picture.

However, I can help you understand the treatment landscape for metastatic ER+ HER2- breast cancer so you can have an informed conversation with your care team.

How Doctors Approach ER+ HER2- Metastatic Breast Cancer

According to NCCN Guidelines for Metastatic Breast Cancer, treatment for hormone receptor-positive (HR+) disease typically starts with endocrine therapy (hormone-blocking treatments) combined with targeted therapies. The general approach considers:

Endocrine therapy options - medications that block estrogen signaling or reduce estrogen production
Targeted therapy combinations - drugs that target specific mutations or pathways (like CDK4/6 inhibitors, mTOR inhibitors, or others)
Your specific biomarkers - whether you have mutations like PIK3CA, ESR1, or others that might guide treatment selection
Prior treatments - what you've received before (if this is recurrent disease)
Your overall health and organ function
Side effect tolerance and personal preferences

Questions to Ask Your Oncologist

To help guide this critical decision, ask your care team:

"Based on my specific biomarker testing, which front-line treatment do you recommend and why?"
"What are the expected response rates and side effects of the options you're considering?"
"Do I have any mutations (PIK3CA, ESR1, etc.) that would favor one treatment over another?"
"Are there clinical trials available for my specific situation?"
"How will we monitor whether the treatment is working, and what's the plan if it stops working?"

Why This Matters

According to NCCN Guidelines, the choice between different endocrine therapy combinations depends on factors unique to your case—factors your oncologist can evaluate but I cannot. Your doctor will consider your complete medical history, imaging results, lab values, and treatment goals.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation. No signup, answered right here.

or Upload your records for answers about your actual case

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →